Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.04 Billion CNY
Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has total liabilities worth CN¥1.04 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Guangdong Zhongsheng Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LuxNet
TWO:4979
|
Taiwan | NT$1.64 Billion |
|
Flat Glass Group Co. Ltd
PINK:FGSGF
|
USA | $19.61 Billion |
|
Pearl Abyss Corp
KQ:263750
|
Korea | ₩319.76 Billion |
|
Nanning Chemical Industry Co Ltd
SHG:600301
|
China | CN¥2.93 Billion |
|
Shenyang Machine Tool Co Ltd
SHE:000410
|
China | CN¥5.29 Billion |
|
Minmetals Capital Co Ltd
SHG:600390
|
China | CN¥101.15 Billion |
|
A10 Network
NYSE:ATEN
|
USA | $418.27 Million |
|
Societatea Nationala de Transport Gaze Naturale Transgaz SA
RO:TGN
|
Romania | RON6.20 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Guangdong Zhongsheng Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Zhongsheng Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total liabilities of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.54 Billion | -20.15% |
| 2023-12-31 | CN¥1.93 Billion | -1.33% |
| 2022-12-31 | CN¥1.96 Billion | +43.63% |
| 2021-12-31 | CN¥1.36 Billion | +18.64% |
| 2020-12-31 | CN¥1.15 Billion | -16.22% |
| 2019-12-31 | CN¥1.37 Billion | +6.08% |
| 2018-12-31 | CN¥1.29 Billion | +14.90% |
| 2017-12-31 | CN¥1.13 Billion | +40.50% |
| 2016-12-31 | CN¥801.23 Million | -34.57% |
| 2015-12-31 | CN¥1.22 Billion | +200.39% |
| 2014-12-31 | CN¥407.63 Million | +71.24% |
| 2013-12-31 | CN¥238.04 Million | +58.25% |
| 2012-12-31 | CN¥150.41 Million | +62.55% |
| 2011-12-31 | CN¥92.54 Million | -3.13% |
| 2010-12-31 | CN¥95.53 Million | -11.92% |
| 2009-12-31 | CN¥108.46 Million | -23.90% |
| 2008-12-31 | CN¥142.53 Million | -14.74% |
| 2007-12-31 | CN¥167.17 Million | +9.32% |
| 2006-12-31 | CN¥152.93 Million | -- |